한글목차

세계 아르테수네이트 정제 시장 전망은 병원 및 클리닉 시장에서의 기회로 인해 유망한 것으로 평가되고 있습니다. 세계 아르테수네이트 정제 시장은 2025-2031년 연평균 복합 성장률(CAGR) 6.1%를 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 전 세계 말라리아 확산 증가, 효과적인 항말라리아 약품에 대한 수요 증가, 병원 치료에서의 채택 확대 등입니다.

• Lucintel의 예측에 따르면, 유형별로는 화합물이 예측 기간 동안 높은 성장세를 보일 것으로 예측됩니다.
• 용도별로는 병원이 더 높은 성장이 예상됩니다.
• 지역별로는 아시아태평양이 예측 기간 동안 가장 높은 성장을 보일 것으로 예측됩니다.

아르테수네이트 정제 시장의 새로운 동향

아르테수네이트 정제 시장은 치료 접근 방식과 의약품의 진보를 재구성하는 새로운 트렌드를 목격하고 있습니다. 주요 동향으로는 병용요법, 제형 개선, 정부 자금 증가, 개발도상국 진출, 디지털 헬스케어의 통합 등이 있습니다.

• 병용요법 : 약제 내성 말라리아 증가로 인해 아르테수네이트 기반 병용요법에 대한 수요가 증가하고 있습니다. 제약사들은 약효를 높이고 내성을 줄이는 2제 병용제제에 집중하고 있습니다.
• 제형 개선 : 약물의 안정성과 생체이용률의 향상으로 아르테수네이트 정제의 효능이 향상되었습니다. 새로운 제형은 보존 기간 연장 및 흡수성 향상을 목표로 설계되어 치료 효과의 향상을 보장합니다.
• 정부 자금 지원 증가 : 각국 정부는 말라리아 치료 프로그램에 대한 투자를 확대하고, 보조금과 규제 완화를 통해 제약사를 지원하며, 아르테수네이트 정제의 가용성을 확대하고 있습니다.
• 개발도상국에서의 개발 확대 : 말라리아가 유행하는 지역에서는 아르테수네이트 정제에 대한 수요가 증가하고 있습니다. 국제보건기구는 제조업체와 협력하여 감염 지역에서의 유통 확대를 위해 노력하고 있습니다.
• 디지털 헬스케어의 통합 : 디지털 플랫폼과 AI를 활용한 모니터링 시스템을 통해 말라리아 진단 및 치료 관리가 개선되고 있습니다. 의료 서비스 제공업체는 디지털 솔루션을 통해 아르테수네이트 정제의 배포 및 치료 순응도를 추적하고 있습니다.

이러한 새로운 트렌드는 아르테수네이트 정제 시장을 변화시키고 있으며, 약물의 효능, 접근성, 최신 헬스케어 솔루션과의 통합을 강화하고 있습니다. 지속적인 기술 혁신이 시장을 주도하고, 전 세계적으로 효과적인 말라리아 치료를 실현할 수 있을 것입니다.

아르테수네이트 정제 시장의 최근 동향

아르테수네이트 정제 시장은 의약품의 기술 혁신, 규제 당국의 승인, 세계 헬스케어에 대한 노력으로 인해 큰 변화의 시기를 맞이하고 있습니다. 다섯 가지 주요 발전이 산업을 형성하고 있으며, 약물의 접근성과 효능을 향상시키고 있습니다.

• 신약 승인 : 여러 국가의 규제 당국이 새로운 아르테수네이트 제제를 승인하여 보다 폭넓은 접근성과 향상된 치료 효과를 보장하고 있습니다.
• 제조의 진보 : 제약회사는 정제의 안정성을 향상시키고, 보존 기간을 연장하고, 확장성을 높이기 위해 첨단 제조 기술을 도입하고 있습니다.
• 민관 파트너십 강화 : 정부와 민간단체가 협력하여 말라리아 취약 지역에서 아르테수네이트 정제에 대한 접근성을 확대하고 대규모 유통을 지원하고 있습니다.
• 약물 내성 연구 : 과학자들은 혁신적인 치료 프로토콜과 대체 제제 개발로 이어질 수 있는 아르테수네이트 내성 이해와 대책 마련에 집중하고 있습니다.
• 시장 확대 전략 : 주요 제약사들은 전략적 파트너십과 현지 생산에 대한 투자를 통해 개발도상국에서의 입지를 확대하고 있습니다.

이러한 주요 발전은 아르테수네이트 정제 시장의 진화를 촉진하여 약물의 가용성, 경제성 및 효능을 향상시키고 있습니다. 지속적인 조사와 전략적 제휴를 통해 시장은 더욱 강화될 것입니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 거시경제 동향과 예측
• 업계 성장 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 아르테수네이트 정제 시장 : 유형별

• 개요
• 유형별 매력 분석
• 모노아로마틱 : 동향과 예측(2019-2031)
• 화합물 : 동향과 예측(2019-2031)

제5장 세계 아르테수네이트 정제 시장 : 용도별

• 개요
• 용도별 매력 분석
• 병원 : 동향과 예측(2019-2031)
• 클리닉 : 동향과 예측(2019-2031)
• 기타 : 동향과 예측(2019-2031)

제6장 지역 분석

• 개요
• 지역별 아르테수네이트 정제 세계 시장

제7장 북미의 아르테수네이트 정제 시장

• 개요
• 북미의 아르테수네이트 정제 시장(유형별)
• 북미의 아르테수네이트 정제 시장(용도별)
• 미국의 아르테수네이트 정제 시장
• 멕시코의 아르테수네이트 정제 시장
• 캐나다의 아르테수네이트 정제 시장

제8장 유럽의 아르테수네이트 정제 시장

• 개요
• 유럽의 아르테수네이트 정제 시장(유형별)
• 유럽의 아르테수네이트 정제 시장(용도별)
• 독일의 아르테수네이트 정제 시장
• 프랑스의 아르테수네이트 정제 시장
• 스페인의 아르테수네이트 정제 시장
• 이탈리아의 아르테수네이트 정제 시장
• 영국의 아르테수네이트 정제 시장

제9장 아시아태평양의 아르테수네이트 정제 시장

• 개요
• 아시아태평양의 아르테수네이트 정제 시장(유형별)
• 아시아태평양의 아르테수네이트 정제 시장(용도별)
• 일본의 아르테수네이트 정제 시장
• 인도의 아르테수네이트 정제 시장
• 중국의 아르테수네이트 정제 시장
• 한국의 아르테수네이트 정제 시장
• 인도네시아의 아르테수네이트 정제 시장

제10장 기타 지역의 아르테수네이트 정제 시장

• 개요
• 기타 지역의 아르테수네이트 정제 시장(유형별)
• 기타 지역의 아르테수네이트 정제 시장(용도별)
• 중동의 아르테수네이트 정제 시장
• 남미의 아르테수네이트 정제 시장
• 아프리카의 아르테수네이트 정제 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간의 경쟁 관계
  • 구매자의 교섭력
  • 공급 기업의 교섭력
  • 대체품의 위협
  • 신규 참여업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 유형별 성장 기회
  • 용도별 성장 기회
• 세계의 아르테수네이트 정제 시장의 최신 동향
• 전략 분석
  • 신제품 개발
  • 인증과 라이선싱
  • 합병, 인수, 계약, 제휴, 합작투자

제13장 밸류체인의 주요 기업 개요

• 경쟁 분석
• Fosun Pharma
• Ipca Laboratories
• Sanofi Aventis
• Ajanta Pharma
• Shin Poong
• Cipla
• Acino

영문목차

The future of the global artesunate tablet market looks promising with opportunities in the hospital and clinic markets. The global artesunate tablet market is expected to grow with a CAGR of 6.1% from 2025 to 2031. The major drivers for this market are the increasing prevalence of malaria worldwide, the rising demand for effective antimalarial drugs, and the growing adoption in hospital treatments.

• Lucintel forecasts that, within the type category, compound is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Artesunate Tablet Market

The artesunate tablet market is witnessing emerging trends that are reshaping treatment approaches and pharmaceutical advancements. Key trends include combination therapies, improved drug formulations, increased government funding, expansion in developing regions, and digital healthcare integration.

• Combination Therapies: The rise of drug-resistant malaria is driving demand for artesunate-based combination therapies. Pharmaceutical companies are focusing on dual-drug formulations that enhance efficacy and reduce resistance.
• Improved Drug Formulations: Advances in drug stability and bioavailability are enhancing artesunate tablet effectiveness. New formulations are designed for extended shelf life and improved absorption, ensuring better treatment outcomes.
• Increased Government Funding: Governments worldwide are increasing investments in malaria treatment programs, supporting pharmaceutical companies through subsidies and regulatory fast-tracking to expand artesunate tablet availability.
• Expansion in Developing Regions: The demand for artesunate tablets is rising in malaria-endemic areas. International health organizations are partnering with manufacturers to ensure wider distribution in affected regions.
• Digital Healthcare Integration: Digital platforms and AI-driven monitoring systems are improving malaria diagnosis and treatment management. Healthcare providers are using digital solutions to track artesunate tablet distribution and treatment adherence.

These emerging trends are transforming the artesunate tablet market, enhancing drug efficacy, accessibility, and integration with modern healthcare solutions. Continued innovation will drive the market forward, ensuring effective malaria treatment globally.

Recent Developments in the Artesunate Tablet Market

The artesunate tablet market is undergoing significant transformations, driven by pharmaceutical innovations, regulatory approvals, and global healthcare initiatives. Five key developments are shaping the industry, improving drug accessibility and effectiveness.

• New Drug Approvals: Regulatory agencies in multiple countries are approving new artesunate formulations, ensuring wider availability and enhanced treatment efficacy.
• Advancements in Manufacturing: Pharmaceutical companies are implementing advanced production techniques to improve tablet stability, extend shelf life, and enhance scalability.
• Increased Public-Private Partnerships: Governments and private organizations are collaborating to expand access to artesunate tablets in malaria-prone regions, supporting large-scale distribution.
• Research in Drug Resistance: Scientists are focusing on understanding and combating artesunate resistance, leading to innovative treatment protocols and alternative formulations.
• Market Expansion Strategies: Leading pharmaceutical firms are expanding their presence in developing nations through strategic partnerships and investments in local manufacturing.

These key developments are driving the evolution of the artesunate tablet market, enhancing drug availability, affordability, and effectiveness. Continued research and strategic collaborations will further strengthen the market.

Strategic Growth Opportunities in the Artesunate Tablet Market

Strategic growth opportunities in the artesunate tablet market are emerging across various applications. Key opportunities include pediatric formulations, hospital-based treatments, telemedicine integration, expansion into non-endemic regions, and government procurement programs.

• Pediatric Formulations: Developing child-friendly artesunate formulations is a significant growth area, improving treatment adherence in younger patients.
• Hospital-Based Treatments: Expanding hospital-based artesunate administration is enhancing malaria treatment efficiency, ensuring timely intervention in severe cases.
• Telemedicine Integration: The adoption of telemedicine platforms is increasing access to malaria diagnosis and artesunate prescriptions, particularly in remote areas.
• Expansion into Non-Endemic Regions: Pharmaceutical companies are targeting travelers and military personnel in non-endemic regions, creating new market opportunities.
• Government Procurement Programs: Governments are investing in large-scale procurement and distribution of artesunate tablets to strengthen malaria eradication programs.

These strategic growth opportunities are driving market expansion and improving access to artesunate tablets. Companies leveraging these opportunities will contribute to more effective malaria control efforts worldwide.

Artesunate Tablet Market Driver and Challenges

The artesunate tablet market is influenced by multiple drivers and challenges, including technological advancements, economic factors, and regulatory dynamics. Understanding these factors is crucial for stakeholders navigating the market landscape.

The factors responsible for driving the artesunate tablet market include:

1. Rising Malaria Cases: The increasing prevalence of malaria in certain regions is driving demand for effective artesunate treatments.

2. Regulatory Support: Governments and health organizations are providing regulatory incentives to accelerate the approval and distribution of artesunate tablets.

3. Technological Advancements: Innovations in pharmaceutical formulations and drug delivery systems are enhancing artesunate efficacy and patient adherence.

4. Expanding Healthcare Infrastructure: Improvements in healthcare facilities, especially in developing nations, are increasing access to artesunate treatments.

5. Growing International Aid Programs: Global health initiatives and funding programs are supporting the large-scale distribution of artesunate tablets in malaria-endemic regions.

Challenges in the artesunate tablet market are:

1. Drug Resistance Issues: The emergence of artesunate-resistant malaria strains poses a significant challenge to treatment effectiveness.

2. High Production Costs: The cost of developing and manufacturing high-quality artesunate tablets remains a barrier for some pharmaceutical companies.

3. Limited Distribution Networks: Ensuring consistent availability in remote and rural regions remains a logistical challenge for healthcare providers.

The artesunate tablet market is expanding due to strong demand and regulatory support, but challenges such as drug resistance and distribution limitations must be addressed. Continued innovation and investment will be essential for sustained market growth.

List of Artesunate Tablet Companies

• Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, artesunate tablet companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the artesunate tablet companies profiled in this report include:
• Fosun Pharma
• Ipca Laboratories
• Sanofi Aventis
• Ajanta Pharma
• Shin Poong
• Cipla
• Acino

Artesunate Tablet Market by Segment

The study includes a forecast for the global artesunate tablet market by type, application, and region.

Artesunate Tablet Market by Type [Value from 2019 to 2031]:

• Monoaromatic
• Compound

Artesunate Tablet Market by Application [Value from 2019 to 2031]:

• Hospital
• Clinic
• Others

Artesunate Tablet Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Artesunate Tablet Market

The artesunate tablet market is evolving due to increasing demand for effective malaria treatments and advancements in pharmaceutical formulations. Key countries, including the United States, China, Germany, India, and Japan, are witnessing significant developments in production, regulatory approvals, and research innovations, driving market growth and accessibility.

• United States: The United States is focusing on expanding access to artesunate tablets for malaria treatment. The FDA has approved new formulations to enhance efficacy, and pharmaceutical companies are investing in research for improved drug stability. Government initiatives are also supporting wider distribution in malaria-prone regions.
• China: China remains a leading producer of artesunate tablets, with ongoing efforts to enhance production capacity and global exports. The government is encouraging pharmaceutical innovation, and research institutes are working on combination therapies to increase treatment effectiveness against resistant malaria strains.
• Germany: Germany is emphasizing high-quality production standards and regulatory compliance for artesunate tablets. Pharmaceutical companies are developing advanced formulations with extended shelf life, and research institutions are collaborating on new treatment protocols to combat drug resistance.
• India: India's pharmaceutical industry is expanding artesunate tablet production to meet domestic and international demand. The government is supporting generic drug manufacturers to ensure affordable access, and research initiatives are exploring novel drug delivery systems to improve patient compliance.
• Japan: Japan is focusing on research-driven innovations in artesunate tablet formulations. Universities and pharmaceutical companies are studying new synthetic approaches to enhance drug potency and reduce side effects. Regulatory agencies are also evaluating fast-track approvals for new malaria treatment solutions.

Features of the Global Artesunate Tablet Market

• Market Size Estimates: Artesunate tablet market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Artesunate tablet market size by type, application, and region in terms of value ($B).
• Regional Analysis: Artesunate tablet market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the artesunate tablet market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the artesunate tablet market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the artesunate tablet market by type (monoaromatic and compound), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Artesunate Tablet Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Monoaromatic: Trends and Forecast (2019-2031)
• 4.4 Compound: Trends and Forecast (2019-2031)

5. Global Artesunate Tablet Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospital: Trends and Forecast (2019-2031)
• 5.4 Clinic: Trends and Forecast (2019-2031)
• 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Artesunate Tablet Market by Region

7. North American Artesunate Tablet Market

• 7.1 Overview
• 7.2 North American Artesunate Tablet Market by Type
• 7.3 North American Artesunate Tablet Market by Application
• 7.4 United States Artesunate Tablet Market
• 7.5 Mexican Artesunate Tablet Market
• 7.6 Canadian Artesunate Tablet Market

8. European Artesunate Tablet Market

• 8.1 Overview
• 8.2 European Artesunate Tablet Market by Type
• 8.3 European Artesunate Tablet Market by Application
• 8.4 German Artesunate Tablet Market
• 8.5 French Artesunate Tablet Market
• 8.6 Spanish Artesunate Tablet Market
• 8.7 Italian Artesunate Tablet Market
• 8.8 United Kingdom Artesunate Tablet Market

9. APAC Artesunate Tablet Market

• 9.1 Overview
• 9.2 APAC Artesunate Tablet Market by Type
• 9.3 APAC Artesunate Tablet Market by Application
• 9.4 Japanese Artesunate Tablet Market
• 9.5 Indian Artesunate Tablet Market
• 9.6 Chinese Artesunate Tablet Market
• 9.7 South Korean Artesunate Tablet Market
• 9.8 Indonesian Artesunate Tablet Market

10. ROW Artesunate Tablet Market

• 10.1 Overview
• 10.2 ROW Artesunate Tablet Market by Type
• 10.3 ROW Artesunate Tablet Market by Application
• 10.4 Middle Eastern Artesunate Tablet Market
• 10.5 South American Artesunate Tablet Market
• 10.6 African Artesunate Tablet Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Artesunate Tablet Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Fosun Pharma
  • Company Overview
  • Artesunate Tablet Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Ipca Laboratories
  • Company Overview
  • Artesunate Tablet Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Sanofi Aventis
  • Company Overview
  • Artesunate Tablet Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Ajanta Pharma
  • Company Overview
  • Artesunate Tablet Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Shin Poong
  • Company Overview
  • Artesunate Tablet Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Cipla
  • Company Overview
  • Artesunate Tablet Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Acino
  • Company Overview
  • Artesunate Tablet Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us